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The correct identiﬁcation of immune-modulatory activity of polysaccharides is often hampered by im-
mune-stimulatory contaminants, with pyrogens such as lipopolysaccharide (LPS) as a very potent ex-
ample. In order to avoid false positive immuno-stimulatory properties to be attributed to poly-
saccharides, accurate quantiﬁcation and inactivation of LPS in test samples is crucial. To quantify LPS in
polysaccharide preparations of different origin and structure we used two different limulus amoebocyte
lysate test kits in two different laboratories. We observed larger variation in detection of LPS con-
tamination between kits than between labs. LPS quantiﬁcation proved unreliable for some poly-
saccharide preparations as spike controls resulted in spike recoveries outside the acceptable range. We
designed a cellular in vitro assay as alternative method to detect the presence of functional LPS. This HEK-
Blue hTLR4 cell culture provides a reliable assay, when combined with a cell viability test, for de-
termining functional LPS in polysaccharide preparations. Finally, to inactivate LPS in polysaccharide
preparations, we setup an alkaline-ethanol-based treatment. With this assay we observed that our
treatment (5 h incubation in 0.1 M NaOH) at 56 °C efﬁciently inactivated LPS in all polysaccharide pre-
parations below immune-stimulatory levels. At this elevated temperature, however, we also observed
minimal to severe degradation of polysaccharide preparations as determined with SEC-RI. Taken to-
gether, we describe methods and precautions to reliably detect and inactivate LPS in polysaccharide
preparations to allow reliable in vitro investigations towards immune-modulatory potential of poly-
saccharide preparations.
& 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years, polysaccharides have received increasing in-
terest as potential immune-modulators (Schepetkin & Quinn,
2006; Wismar, Brix, Frokiaer, & Laerke, 2010). Anti-infectious
(Estrada et al., 1997; Jung et al., 2004; Murphy et al., 2008; Yun
et al., 1998) and anti-tumor (Harada, Itashiki, Takenawa, & Ueya-
ma, 2010; Hong et al., 2004; Modak, Koehne, Vickers, O’Reilly, &
Cheung, 2005) activities of several polysaccharides have been
demonstrated in animal models. The mechanisms behind these
effects are only partially understood, even though a range of
polysaccharide receptors has been identiﬁed on various immune
cells (Wismar et al., 2010). These carbohydrate binding receptorsLtd. This is an open access article u
.belong to the group of pattern recognition receptors (PRRs) that
include c-type lectins, nucleotide-binding oligomerization domain
(NOD)-like receptors, scavenger receptors and toll-like receptors
(TLRs) (Mogensen, 2009).
In vitro and ex vivo studies investigating interactions between
polysaccharides and immune cells can make a signiﬁcant con-
tribution to improve understanding of the diverse effects of
polysaccharides on the immune system. However, the potential
presence of immuno-stimulatory contaminants in polysaccharide
preparations, such as microbial pyrogens, complicates this task.
One of the most potent and ubiquitous immune-stimulatory con-
taminants is lipopolysaccharide (LPS) or endotoxin. LPS is com-
prised of three regions: the O-polysaccharide; the core compo-
nent; and lipid A. The O-polysaccharide comprises the outer do-
main of LPS and consists of repeating oligosaccharide subunits that
can vary greatly between bacterial strains (Lerouge et al., 2001).
The core component, consisting of hetero-oligosaccharides, links
the O-chain to lipid A. The biological activity of LPS is harboured innder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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conserved region of LPS (Tzeng, Datta, Kolli, Carlson, & Stephens,
2002). It consists of a phosphorylated glucosamine hetero-dis-
accharide acetylated with 6 fatty acid chains (Lerouge et al., 2001).
Immune responses to LPS are initiated via the LPS receptor com-
plex, which follows sub-sequential actions of LPS binding protein
(LBP), CD14, lipid binding accessory protein (MD-2) and TLR-4
(Rossol et al., 2011). This complex can induce cytokine secretion by
dendritic cells in vitro to LPS concentrations as low as 20 pg/ml
(Schwarz, Schmittner, Duschl, & Horejs-Hoeck, 2014; Tynan,
McNaughton, Jarnicki, Tsuji, & Lavelle, 2012).
There are many examples of false-positive immuno-stimulatory
activities of plant extracts or polysaccharide preparations reported
in the scientiﬁc literature that where later attributed to LPS con-
tamination (Pugh et al., 2008; Rieder et al., 2013; Tamta et al.,
2008). To obtain valuable results from in vitro and ex vivo studies
regarding immuno-modulation, adequate endotoxin control is
crucial (Gertsch, Viveros-Paredes, & Taylor, 2011). Activation of the
clotting cascade of limulus amoebocyte lysate (LAL) from the
horseshoe crab (Limulus polyphemus) has been the standard assay
for LPS quantiﬁcation for many years due to its high sensitivity
(Gutsmann et al., 2010). However, the quantiﬁcation of LPS is
particularly difﬁcult in polysaccharides as most methods have
been developed for protein samples. In addition, LAL-based assays
have also been reported to give “varying results” for protein pre-
parations (Schwarz et al., 2014). One standard method to block LPS
activity in vitro is the use of Polymyxin B (PmB), an antibiotic with
a high binding afﬁnity for Lipid A (Moore, Bates, & Hancock, 1986).
Even though this method is convenient and effective for many
samples, it is not universally applicable. In some polysaccharide
preparations, PmB-mediated LPS inactivation is ineffective (Rieder
et al., 2013). Interestingly, PmB is effective upon degradation of the
polysaccharide sample. The ineffectiveness of PmB in certain
polysaccharide preparations may therefore be due to the forma-
tion of a polysaccharide-LPS complex that hinders binding of LPS
to PmB (Rieder et al., 2013). Furthermore, PmB ability to inhibit
LPS-induced cytokine secretion from dendritic cells was shown to
be incomplete (Tynan et al., 2012). Alternative reliable methods for
LPS quantiﬁcation in polysaccharide samples are therefore needed.
Here, we describe LPS quantiﬁcation and inactivation in different
polysaccharide preparations. We compare the LAL-based Endozyme
and ToxinSensor kits in two different laboratories and demonstrate
that these kits are not universally applicable for polysaccharide pre-
parations. As an alternative, we show that HEK-Blue hTLR4 cells can
reliably determine functional LPS levels. We next applied an alkaline-
ethanol treatment at 4 °C and 56 °C to inactivate LPS in these poly-
saccharide preparations. At 56 °C we observed LPS inactivation below
detection thresholds of the HEK-Blue hTLR4 assay. To monitor possible
degradation of the polysaccharides, size exclusion chromatography
(SEC-RI) was selected as a screening tool which revealed poly-
saccharide- and temperature-dependent changes in molar masses.2. Materials and methods
2.1. Cell culture
HEK-Blue hTLR4 cells (InvivoGen, Toulouse, France) were sub-
cultured in DMEM (Gibco, Life Technologies, Bleiswijk, The Neth-
erlands) with 10% fetal bovine serum (FBS; Gibco) once per week
and medium was refreshed twice per week.
2.2. Polysaccharide preparations
The polysaccharide preparations employed in this study origi-
nate from baker's yeast (Saccharomyces cerevisiae), Shiitakemushroom (Lentinus edodes), wheat (Triticum aestivum), oat (Avena
sativa) and apple (Malus domestica). Water soluble 1,3/1,6 beta-
glucan from yeast (Wellmune Soluble) was provided by Biothera
(Eagan, MN, USA) and contained 490% β-glucan (according to the
manufacturer). Linear, mixed linkage β-1,3/1,4-glucan from oat
with a purity of 490% (OBG90) was provided by Swedish Oat
Fiber (Bua, Sweden). A water soluble, arabinoxylan-enriched,
fraction from wheat (Naxus) (55% arabinoxylan based on sum of
arabinose and xylose) was provided by Bioactor (Maastricht, The
Netherlands). A rhamnogalacturonan-I fraction from apple pectin
(RG-1) (76% pectin based on the sum of rhamnose, arabinose,
galactose and uronic acid) was provided by INRA (INRA, Nantes,
France). Lentinan containing extract from shiitake (LCES; 51% β-
glucan based on starch-free glucose content) was acquired based
on a previously described method (Tomassen, Hendrix, Sonnen-
berg, Wichers, & Mes, 2011). In brief, 660 gr fresh shiitake was
homogenized in a magimix blender. The grounded pieces were
added to 1 l of boiling tap water. The samples were further
homogenized with a blender and boiled for 8 h. After O/N cooling
the extracts were centrifuged at 2800 rpm for 30 min. The su-
pernatant was collected and precipitated O/N by addition of 1 vol
of 96% ethanol. The precipitate was collected and lyophilized. The
constituent sugar content used for purity estimation is based on
alditol acetate derivatives quantiﬁed by GC after acidic hydrolysis
and derivatization (Blakeney, Harris, Henry, & Stone, 1983).
2.3. Preparation of polysaccharide samples for LPS quantiﬁcation
and cell culture experiments
At lab 1, the polysaccharide samples were dissolved in en-
dotoxin free water (o0.005 EU/ml, G-Biosciences, MO, USA) at a
concentration of 1 mg/ml in endotoxin free centrifuge tubes
(o0.05 EU/ml following water washing of tubes) by incubation in
a boiling water bath for 1 h. Prior to LPS quantiﬁcation by the LAL
method, samples were diluted stepwise (1:10) with endotoxin free
water. At lab 2, the polysaccharide samples were dispersed in
endotoxin free water (Life Technologies-Gibco, Bleiswijk, The
Netherlands) in endotoxin-free glass vials (Hyglos, Bernried am
Stranberger See, Germany) at a concentration of 3 mg/ml and
stirred for 6 h and stored overnight (O/N) at ambient temperature
(RT). Subsequently, samples were diluted with endotoxin free
water to 0.75 or 1 μg/ml for quantiﬁcation of LPS by the LAL
method. For use in cell culture experiments, polysaccharides were
dispersed O/N in appropriate endotoxin free culture medium at
40 °C.
2.4. LPS quantiﬁcation
2.4.1. LPS quantiﬁcation with commercial LAL based test kits
LPS quantiﬁcation in the different polysaccharide samples
(prepared as described above) was conducted with two different
commercial test kits. Both test kits did not contain the speciﬁc
recognition protein for β-glucan (factor G). ToxinSensor™ Chro-
mogenic LAL Endotoxin Assay Kit was purchased from GenScript
(GenScript, NJ, USA). EndoZymes test kit, which contains re-
combinant factor C, was purchased from Hyglos (Hyglos GmbH,
Bernried am Starnberger See, Germany). Both test kits were used
according to the manufacturer's instructions. For the EndoZymes
test kit, this instruction included the use of spike controls along-
side all tested polysaccharides. Linear regression models were
used for both kits to construct the calibration curves based on log
concentration and log ﬂuorescence or log absorption readings at
both labs. For the Endozyme test kit, LPS standards in a range from
0.005 to 5 EU/ml were used. In comparison, the ToxinSensor™ test
kit can be used either in the range of 0.01-0.1 or in the range of
0.1–1 EU/ml. At both labs, spiking was performed by adding LPS to
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polysaccharides. Dilutions were chosen to achieve a measured
endotoxin concentration of approximately 0.5 EU/ml in the non-
spiked sample in order to ensure a spike value of similar magni-
tude as the measured endotoxin concentration of the diluted
samples.
2.4.2. LPS quantiﬁcation with HEK-Blue hTLR4 assay
HEK-Blue hTLR4 cells are transgenic for the cell surface ex-
pressed hTLR4, MD-2 and CD14 receptors and contain a down-
stream reporter system resulting in secretion of secreted em-
bryonic alkaline phosphatase (SEAP) under the control of NFκB
and AP1 promotors. HEK-Blue hTLR4 cells were detached using a
cell scraper when 90–95% conﬂuence was reached and 0.5106
cells were transferred to each well of a 96-well Poly-D-Lysine
coated plate. After O/N incubation at 37 °C in an atmosphere
containing 5% CO2, we added 0.0001-100 EU/ml LPS (E. coli O11:
B4, 1 EU≡0.15 ng/ml, Sigma, St. Louis, MO, USA) or polysaccharides
to a ﬁnal concentration of 300 ng/ml or 2.5 mg/ml to the cells and
the plate was incubated for 8 h (37 °C; 5% CO2). TLR4 stimulation
resulted in SEAP secretion, which was quantiﬁed by mixing 20 μl
of supernatant (depleted from cells by centrifugation at 450g for
5 min) with 180 μl of Quanti-Blue™ in a new ﬂat bottom 96-well
plate. The plate was incubated for 3 h at 37 °C and absorption at
655 nm was determined every hour using a spectrophotometer
(TECAN, Giessen, The Netherlands).
2.5. Alkaline-ethanol treatment for LPS inactivation
Before LPS inactivation, all labware was washed 3 times with
1.0 M (M) NaOH and rinsed with LPS-free MilliQ. As an initial trial,
6 mg of lentinan isolated from shiitake (isolated as described in To-
massen et al. (2011) was dissolved in 1 ml of 0.1, 0.25, 0.5, 1 or 2 M
NaOH. During the incubation at 56 °C (gently shaken) a sample of
250 μl was taken after 30, 150 and 300 min. Directly after sampling
equal molar amounts of HCl were added for an approximate neu-
tralisation. The samples were 4 times diluted with LPS-free water
(Lifetechnologies-Gibco) and the remaining LPS concentration was
measured using the ToxinSensor test kit. For the preparative ex-
periment, 50 mg of all polysaccharides were mixed with 10 ml of
0.1 M or 0.5 M NaOH in 60% ethanol in a 50 ml tube. The poly-
saccharides were incubated for 5 h at 4 °C or 56 °C while mildly
shaken. Next, 1 ml of 1.0 M or 5.0 M HCl was added for an approx-
imate neutralization of the mixture. Finally, absolute ethanol was
added to give a combined total volume of 40 ml and samples were
stored O/N at 4 °C. Polysaccharides were recovered by centrifugation
for 20 min at 3320g and washed three times with 40 ml 60% ethanol.
Finally, polysaccharides were lyophilized.
2.6. Cell viability assay
Cell viability of HEK-Blue hTLR4 cells after stimulation was
determined with the MTT test. Following polysaccharide stimu-
lations, cells were washed and incubated with 10 μl medium
containing 5.5 mg/ml MTT (Merck, Darmstadt, Germany) for 2 h at
37 °C and 5% CO2. Next, 10 μl DMSO: ethanol (1:1) was added to
each well and the plate was mildly shaken for 5 min. The absor-
bance measured at 570 nm using an ELISA plate reader (TECAN
inﬁnite
s
M200 pro NanoQuant) showed the conversion of MTT to
formazan indicative of mitochondrial activity and cell viability.
2.7. Size exclusion chromatography with refractive index detection
(SEC-RI)
Original and alkaline-ethanol treated samples were dissolved
in eluent (50 mM Na2SO4) at approximately 1.5 mg/ml. The HPLCsystem consisted of a pump (Dionex P680), a Spectaphysics
AS3500 auto injector, a guard-column (Tosoh PWXL), two serially
connected columns (Tosoh TSK-gel G6000 PWXL followed by
G5000 PWXL), maintained at 40 °C and a refractive index detector
(Shimadzu RID-6A). The eluent was delivered at a ﬂow rate of
0.5 ml/min. Injection volume was 95 μl and raw data was collected
by Chromeleon software v. 6.8 (Dionex). All data was processed by
PSS WINGPC Unichrome software (Polymer standard service,
Mainz, Germany) and analysed by peak position calibration re-
lative to pullulan standards ﬁtted with a proprietary third order
polynomial regression algorithm (PSS 3).3. Results
3.1. LPS quantiﬁcation in polysaccharide preparations with com-
mercial LAL-based test kits
The LPS content of the different polysaccharide samples was
measured in two different labs with two different LAL-based test
kits, Endozymes and ToxinSensor™. Analysis of LPS standards
resulted in linear calibration curves with coefﬁcients of determi-
nation above 0.968 for all Endotoxin and 0.952 for all ToxinSensor
measurement series (Supplementary ﬁg. 1). As described in the
methods section, the two test kits strongly differ in the ranges of
detection. The Endozyme kit detection range is from 0.005 EU/ml
to 5 EU/ml and the ToxinSensor detection range is from 0.01 to
0.1 or 0.1–1 EU/ml. The back calculated concentrations of the dif-
ferent standard solutions are shown in Table 1 for all measure-
ment series. Except for one out of 20 data points, all back calcu-
lated standard concentrations for the Endozyme kit were within
the acceptable range stated by the manufacturer (60–140%; Ta-
ble 1). Although the manufacturer of the ToxinSensor kit does not
provide a range, results demonstrated a similar back calculated
standard range as the Endozyme kit with one outlier (54%) out of
12 data points outside the 60–140% range. Despite these standar-
dised calibration curves the absolute values of determined LPS
contents in the different polysaccharide preparations generally
deviated between the two test kits and the two labs, although
trends were similar. The largest difference observed between labs
for the Endozyme test kit was around 7-fold, e.g. lab 1 and 2 de-
tected 115 and 756 EU/mg for the RG-1 sample, respectively
(Fig. 1A and B). The smallest difference in detection was 2.5-fold,
e.g. lab 1 and 2 detected 0.05 EU/mg and 0.02 EU/mg, respectively,
for the Wellmune Soluble sample. For the ToxinSensor kit trends
were also similar between labs but the highest difference in de-
tection was 33-fold, e.g. lab 1 and 2 detected 525 and 16 EU/mg,
respectively, in the Naxus sample (Fig. 1C and D). The smallest
difference in detection was again observed for the Wellmune So-
luble sample and was about 1.3-fold, e.g. lab 1 and 2 detected 0.05
EU/mg and 0.04 EU/mg, respectively. Observed differences be-
tween test kits were largest for Naxus (17-fold; Endozyme: 31
versus ToxinSensor: 525 EU/mg) and OBW90 (157-fold; Endozyme:
0.05 versus ToxinSensor: 7.93 EU/mg) in lab 1 (Fig. 1A and C). In lab
2, Naxus (7-fold; Endozyme: 104 versus ToxinSensor: 16 EU/mg)
and OBW90 (142-fold; Endozyme: 0.02 versus ToxinSensor: 2.84
EU/mg) demonstrated the largest variation in LPS detection be-
tween the two test kits (Fig. 1B and D).
For the EndoZymes test kit, the manufacturer instruction re-
quires the inclusion of spike controls alongside all tested samples.
Measured LPS values of samples are only deemed valid if the re-
covery of the corresponding spike controls is between 50% and
200%. In lab 1, LPS measurements in Naxus and RG-1 could not be
validated because the recovery of the corresponding spike controls
was 30% and 59%, respectively (Fig. 1E). For lab 2 the averages of
spike control recoveries were all between 50% and 200% (Fig. 1F).
Table 1
Endotoxin test kit performance evaluation by assessing internal LPS standards.
Endozymea ToxinSensorb
Nominal standard concentrations
[EU/ml]d
Back calculated standard concentrationsc Nominal standard concentrations
[EU/ml]e
Back calculated standard
concentrationsc
Test 1 Test 2 Test 3 Test 4 Test 5 Test 1 Test 2 Test 3
5 104 102 89 109 139 1 96
0.5 78 95 123 98 75 0.5 120
0.05 104 102 93 81 65 0.25 95
0.005 84 n.a 98 116 146 0.1 54 97 96
0.05 117 120
0.025 90 86
0.01 78 77
n.a.¼not applicable
a Test 1 and 2 were performed by lab 1 and test 3–5 by lab 2.
b Test 1 was performed by lab 1 and test 2 and 3 by lab 2.
c Back calculations of standard concentrations were performed using the standard curves presented in supplementary Fig. 1 and shown as percentage of nominal.
d Concentrations provided by Endozyme manufacturer to construct the standard curve.
e Concentrations provided by ToxinSensor manufacturer to construct the standard curve.
C. Govers et al. / Bioactive Carbohydrates and Dietary Fibre 8 (2016) 15–2518However, the high standard deviation of the spike recovery values
for RG-1 indicates problems with LPS determination in the RG-1
sample also in lab 2. These results demonstrate difﬁculties to ob-
tain reliable absolute values for LPS contents in different poly-
saccharide samples with two commercial LAL based test kits.
3.2. LPS detection in polysaccharide preparations based on HEK-Blue
hTLR4 reporter cells
As an alternative method to detect LPS in polysaccharides we
used HEK-Blue hTLR4 cells that are transfected with the LPS re-
ceptor complex. LPS-mediated TLR4/MD2/CD14 activation was
quantiﬁed by increased absorbance following SEAP activity. To
verify the sensitivity of the HEK-Blue hTLR4 cells and quantify LPS
contamination in polysaccharide preparations using the HEK-Blue
hTLR4 cells, we stimulated the cells with different LPS con-
centrations (Fig. 2A). Using a 5-parameter logistic curve ﬁtting to
convert SEAP reporter activity into EU/ml this revealed a detection
range between 0.011 and 1.176 EU/ml for the HEK-Blue hTLR4 cells.
Stimulation of HEK-Blue hTLR4 cells with a number of poly-
saccharides at 2.5 mg/ml visually appeared to result in reduced
cell viability, which was conﬁrmed with an MTT assay (Fig. 2B).
Surprisingly, OBW90 also reduced cell viability when using a re-
lative low concentration (i.e., 300 ng/ml), in contrast to the other
polysaccharides (data not shown). Measurements with low poly-
saccharide concentrations resulted in signiﬁcant HEK-Blue hTLR4
responses and therefore indicated LPS contaminations in LCES
(2600 EU/mg), Naxus (53 EU/mg) and RG-1 (121 EU/mg) (Fig. 2C).
In contrast, responses to Wellmune Soluble and OBW90 samples
were below detection levels of 0.011 EU/ml, which, due to the low
polysaccharide concentrations, only indicates that LPS con-
taminations are below 38EU/mg. Surprisingly, detected LPS con-
taminations were only 2.3-fold (LCES), 1.2-fold (Naxus) and 3.5-
fold (RG-1) different between the average Endozyme kit results
(Fig. 1A and B) and HEK-Blue hTLR4 cells (Fig. 2C). In addition, the
lower detection limit of the HEK-Blue hTLR4 assay (i.e., 0.011 EU/
ml) is also similar to the Endozyme kit (i.e., 0.005 EU/ml).
3.3. Optimal conditions for alkaline-ethanol-based LPS inactivation
To allow analysis of in vitro and ex vivo immune-modulatory
potential of the polysaccharides we needed to remove LPS activity.
To this end we adapted a method based on alkaline-ethanol
treatment. In a pilot experiment a lentinan extract (Tomassen
et al., 2011) was treated at 56 °C with different alkalineconcentrations and for various incubation times to determine
conditions for maximal LPS inactivation. LPS contents after treat-
ments were initially measured using the ToxinSensor test kit. The
relative LPS content was lowest after 2.5 h with 0.5 M NaOH or 5 h
with 0.1 M NaOH (Supplementary ﬁg. 2). For the main experiment,
the NaOH concentration of 0.1 M in combination with an incuba-
tion time of 5 h was selected and we included an additional
temperature setting at 4 °C. We selected these conditions because
a lower alkaline concentration and a lower treatment temperature
are assumed to lead to less degradation of the polysaccharides.
3.4. Alkaline-ethanol treatment of polysaccharide preparations
In the main experiment, the above selected alkali treatments
(0.1 M NaOH in 60% ethanol at 4 °C and 56 °C) were applied to all
samples. After treatment, the relative yield of the treated samples
was determined by weighing the lyophilized samples (Supple-
mentary ﬁg. 3A). This resulted in yields between 60% and 110%. In
general, RG-1 and Wellmune Soluble showed the lowest yields
which might be related to incomplete recovery during ethanol
precipitation. The efﬁcient removal of neutralized alkali was con-
ﬁrmed by osmolality measurements (Supplementary ﬁg. 3B). This
shows that the lyophilized samples did not contain any signiﬁcant
amounts of salt, which is important both with respect to calcu-
lated yields and because increased osmolality could affect cell
viability in subsequent cell culture experiments.
3.5. Effect of alkali-ethanol treatment on LPS contaminations in
polysaccharide preparations
LPS contamination of the alkaline-ethanol treated poly-
saccharide preparations was estimated with the EndoZyme test
kit. The LPS contamination detected in the treated polysaccharides
at both temperatures was lower compared to the untreated
polysaccharides (Fig. 3A). Treatment at 4 °C resulted in detectable
residual LPS in the LCES and Naxus samples, whereas treatments
at 56 °C reduced LPS contaminations below the detection limit
(0.0017 EU/mg) for all polysaccharides. However, the corre-
sponding spike controls of the treated polysaccharides were out-
side the acceptable range for most of the samples (Fig. 3B). Only
Wellmune Soluble treated at 4 °C and 56 °C and LCES and Naxus
treated at 4 °C demonstrated spike recovery between 50% and
200%. Therefore, the measured LPS contents are strictly only valid
for these samples. In order to validate endotoxin concentrations in
all preparations we employed the HEK-Blue hTLR4 reporter cell
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Fig. 1. LPS content and spike recovery in polysaccharide preparations as determined by LAL-based test kits. LPS contamination in LCES, Wellmune Soluble, OBW90, Naxus
and RG-1 was determined using the EndoZyme test kit (A, B) or the ToxinSensor test kit (C, D) at lab 1 (A, C) and lab 2 (B, D). Spike recovery (percentage of detected spike) in
the polysaccharide preparations was determined with the EndoZyme test kit at lab 1 (E) and lab 2 (F). The dotted lines represent the threshold level of a valid spike recovery.
Bars represent averagesþSEM of n¼2–6 measurements.
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Fig. 2. HEK-Blue hTLR4 cells allow determination of functional LPS contamination
in polysaccharides. HEK-Blue hTLR4 cells were incubated for 8 h with 0, 0.0001,
0.001, 0.01, 0.1, 1, 10, or 100 EU/ml LPS (A), or 2.5 mg/ml (B) or 300 ng/ml
(C) untreated LCES, Wellmune Soluble, OBW90, Naxus and RG-1. In A alkaline
phosphatase activity was determined and LPS concentrations of n¼6 independent
measurements are log(10) transformed and absorbance values plotted7standard
error using a 5-parameter logistic equation with best ﬁt values for EC50, lower and
upper detection limits depicted in EU/ml. The lower and upper detection limits are
indicated in the graph with vertical dashed lines. In B MTT was added and con-
version to formazan was detected by measuring absorbance at 570 nm and shown
relative to medium (set at 100%). Bars represent averagesþSEM of n¼4 to 6 in-
dependent measurements. LPS contaminations in polysaccharides are depicted in C
in EU/mg following analysis of alkaline phosphatase activity with the 5-parameter
logistic equation and correction for the dilution factor. Bars represent aver-
agesþSEM of n¼3 independent measurements. Statistically signiﬁcant differences
of polysaccharides to medium were calculated with two-tailed Student's t-tests:
*¼po0.05;**¼po0.005.
Fig. 3. Endozyme measurements suggest efﬁcient LPS inactivation by alkaline-
ethanol treatment but spike recovery indicate results are unreliable. LPS con-
tamination of untreated or at 4 °C and 56 °C alkaline-ethanol treated LCES, Well-
mune Soluble, OBW90, Naxus and RG-1 was determined with the Endozyme test
kit (A) and spike recovery was determined in treated samples (B). Bars represent
averagesþSEM of n¼1 or 2 independent measurement and N.D. is non-detectable.
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signiﬁcant responses (data not shown), demonstrating the treat-
ment was effective but also only indicating LPS contaminations
were below 38 EU/mg. Surprisingly, analysing 2.5 mg/ml of treated
LCES and Naxus did not, in contrast to untreated polysaccharides,
result in reduced cell viability (Fig. 4A). HEK-Blue hTLR4 responses
to 2.5 mg/ml stimulation of treated polysaccharides conﬁrmed
that LPS contaminations are reduced at both temperatures and
most pronounced following treatment at 56 °C (Fig. 4B). In fact,
this reduces LPS contamination in LCES and Naxus below detectionlimit (0.0046 EU/mg) and RG-1 (0.0143 EU/mg) below LPS con-
taminations observed for Wellmune Soluble. Indeed, the increased
sensitivity resulting from testing higher concentrations of poly-
saccharides demonstrated low but detectable LPS contamination
in Wellmune Soluble (i.e., 0.177 EU/mg). For OBW90 the LPS con-
tamination was also below threshold levels, but measurements
were unreliable due to the reduced cell viability.
3.6. Effect of alkali-ethanol treatment on molar mass distributions of
polysaccharide preparations
To investigate whether the polysaccharides are markedly de-
polymerized during treatment, we measured the molar mass
distributions (MMD) of the treated and untreated polysaccharides
using SEC-RI. For the unimodal distributions of OBW90 and Naxus
we reported the weight average MW (Mw) relative to pullulan
standards (Table 2). OBW90 alkaline-ethanol treatment at 4 °C did
not lead to any degradation, while treatment at 56 °C resulted in a
profound degradation with a high variation between treatment
replicates (Fig. 5A and Table 2). For Naxus there was no difference
between treatment at 4 °C and at 56 °C. Both led to a slight
broadening of the molar mass distribution and a slight increase of
the calculated Mw (Fig. 5B and Table 2).
For a quantitative comparison of the polysaccharides with a
polymodal distribution we divided the distributions into two
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Fig. 4. HEK-Blue hTLR4 show that alkaline-ethanol efﬁciently inactivated LPS in
polysaccharide preparations. HEK-Blue hTLR4 cells were incubated for 8 h with
2.5 mg/ml of untreated Wellmune Soluble and OBW90 and at 56 °C alkaline-
ethanol treated LCES, Naxus, and RG-1. In A we detected formazan following in-
cubation with treated LCES, Naxus and RG-1 as described for Fig. 2B. Bars represent
averages þ SEM of n¼4–6 independent measurements. No statistically signiﬁcant
differences of polysaccharides to mediumwere found as calculated with two-tailed
Student's t-tests. In B we detected alkaline phosphatase activity as described for
Fig. 2C. Bars represent averagesþSEM of n¼2 to 5 independent measurements.
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as the corresponding contribution of each peak to the total area
(Table 2). The polymodal molar mass distribution of RG-1 can be
roughly divided into one peak with Mw of around 10,000 g/mol
(peak A), constituting 55% of the polysaccharide, and one peak
with Mw around 100,000 g/mol (peak B), constituting about 45% of
the polysaccharide (Fig. 5C and Table 2). Alkaline-ethanol treat-
ment at 4 °C did not change the Mw of the two peaks, but resulted
in a change in their proportion. There was a large variation in the
effect of treatment at 56 °C on RG-1, which resulted in a profound
change of the B peak in one of the parallels, while the other more
closely resembled the MMD of the untreated sample. In the un-
treated LCES the B peak showed a Mw of 12,000,000 g/mol andTable 2
Molar mass distributions of untreated and alkaline-ethanol treated polysaccharides pre
Sample Distributiona Parameterb U
OBW90 unimodal Mw (g/mol) 1
area (%) 1
Naxus unimodal Mw (g/mol) 4
area (%) 1
LCES Peak A Mw (g/mol) 3
area (%) 2
Peak B Mw (g/mol) 1
area (%) 7
RG-1 Peak A Mw (g/mol) 8
area (%) 5
Peak B Mw (g/mol) 1
area (%) 4
Wellmune Soluble Peak A Mw (g/mol) 6
area (%) 3
Peak B Mw (g/mol) 8
area (%) 6
a Unimodal distributions show only one peak. To facilitate a clear presentation of the
(Peak A and B).
b The shown parameters include the weight average molecular mass (Mw) of the
contribution to the total area in %.
c Untreated polysaccharide preparations were measured once.
d The treatment of polysaccharide preparations with alkaline-ethanol at 4 °C or 56constituted about 74% of the sample (Fig. 5D and Table 2). The A
peak was deﬁned as the broad remainder of the distribution with a
Mw of 370,000 g/mol and constituted 26% of the sample. Alkaline-
ethanol treatment of LCES at 4 °C or 56 °C resulted in a dramatic
decrease of the area of the B peak to 20% and 11%, respectively, of
the total area even though the Mw of the B peak remained above
10,000,000 g/mol for both treatment temperatures (Table 2). The A
peak correspondingly increased in proportion, with a slight re-
duction in Mw. Alkaline-ethanol treatment of Wellmune Soluble at
4 °C did not affect the MMD of the polysaccharide except for a
slight decrease in Mw of the B peak (from 86,000 to 53,000 g/mol;
Fig. 5E and Table 2). Treatment at 56 °C, on the other hand, re-
sulted in a change of the MMD distribution into a broad but es-
sentially unimodal distribution.4. Discussion
To detect in vitro polysaccharide-mediated immune-modula-
tion it is crucial to control endotoxin contaminations. Here we
describe the quantiﬁcation of LPS in different polysaccharide
preparations with 2 commercial kits and a cellular system. In both
kits, LPS detection is depending on Lipid A-mediated activation of
complement factor C and the following LAL cascade. According to
the back calculated standards, both kits performed within speci-
ﬁcation. The LPS content of an external LPS control (E.coli O11: B4,
Sigma) was accurately quantiﬁed with both test kits (data not
shown). Additionally, the Endozyme test kit has given reliable
values and valid spike controls for a range of protein samples
tested in both labs (data not shown). However, the lack of valid
spike controls for some of the polysaccharide samples (especially
the alkaline-ethanol treated polysaccharides; Fig. 3B) and varying
results between the ToxinSensor and Endozyme kits demonstrated
that these kits cannot be universally used for all polysaccharide
preparations. This is in agreement with the experience of a spe-
cialist ultrapure biopolymer producer that found speciﬁc LPS
quantiﬁcation kits must be selected for each different type of
polysaccharide (Personal Communication, Novamatrix, FMC
Health and Nutrition, Sandvika, Norway). We have previously
shown that a cereal β-glucan inhibited the binding of LPS to
polymyxin (Rieder et al., 2013), probably due to steric hindrances.parations.
ntreatedc 4 °Cd 56 °Cd
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observed trends, all polymodal distributions were divided into two peak areas only
different peak areas calculated relative to pulullan standards and their relative
°C was performed twice and both replicate samples were analysed.
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Fig. 5. Molar mass distributions demonstrate effects of alkali-ethanol treatment on polysaccharide preparations. Molar mass distributions of OBW90 (A), Naxus (B), RG-1 (C),
LCES (D) and Wellmune Soluble (E) were determined before (solid line) and after alkaline-ethanol treatment at 4 °C (dotted line) and 56 °C (dashed line). The ﬁgure shows
weight-differential molar mass distributions in logarithmic scale (Fw(logM)) relative to pullulan. Alkaline-ethanol treatment at 4 °C and 56 °C of each polysaccharide pre-
paration was performed twice and both replicate samples are presented.
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ence the LPS activity/availability in LAL assays.
To circumvent some of the problems with the LAL-based test kits
we adapted an alternative method to detect LPS in polysaccharides.
The employed HEK-Blue hTLR4 reporter cells are transgenic for the
cell surface expressed hTLR4, MD-2 and CD14 receptors and contain
a downstream reporter system resulting in secretion of secreted
embryonic alkaline phosphatase (SEAP) under the control of NFκB
and AP1 promotors. A major advantage of using this cell assay is that
its method of LPS detection is representative for other cellular (im-
mune) assays. Although both LAL-based kits and CD14/MD2/TLR4-
mediated cellular recognition are based on detection of lipid A, only
cellular recognition requires lipid A to adopt a certain aggregate
conformation (Gutsmann et al., 2010) which can lead todiscrepancies in LPS detection between both methods. Surprisingly,
however, detected LPS contaminations and lower detection thresh-
olds were similar between the Endozyme test kit and the HEK-Blue
hTLR4 cells. The detection limit of the HEK-Blue hTLR-4 assay is also
below lower limits of LPS responses observed by various immune cell
types (0.2 EU/ml (Schwarz et al., 2014)). The HEK-Blue hTLR4 as-
says could lead to false-positive results when polysaccharides have
potential to interact with the TLR-4 receptor as has been demon-
strated in multiple studies (Capitan-Canadas et al., 2014; Chen et al.,
2009; Lehmann et al., 2015; Li et al., 2016; Ortega-Gonzalez et al.,
2014; Sahasrabudhe, Dokter-Fokkens, & de Vos, 2016; Tsuji et al.,
2015; Vancraeyneste et al., 2016; Vogt et al., 2013; Zhu et al., 2014).
However, none of those studies verify the absence of LPS con-
taminations below 0.2 EU/ml, leaving the distinct possibility the
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Another potential limitation of the cellular assay is that compounds
might reduce cell viability leading to false-negative LPS contamina-
tion. Initial testing of untreated samples therefore requires titrations
of the test compound to determine cell viability and prevent false
negative alkaline phosphatase responses. It appeared that HEK-Blue
hTLR4 cells are sensitive to high concentrations of polysaccharides
with high LPS contaminations (Fig. 2B) since similar polysaccharide
concentrations following alkaline-ethanol treatment at 56 °C did not
affect cell viability (Fig. 4A). This notion was substantiated by the fact
that untreated Wellmune Soluble, containing o0.2 EU/mg LPS, only
induced limited reduction in cell viability (94%). In contrast, un-
treated OBW90 also has a low LPS contamination as determined with
the Endozyme kit and spike control in both labs (0.035 EU/mg;
Fig. 1), but did reduce cell viability (Fig. 2B). When stimulating im-
mune cells (i.e., primary macrophages) with OBW90 we observed a
signiﬁcantly lowered mRNA yield, indeed also suggesting lowered
cell viability and/or increased cell death. However, follow-up analysis
using ﬂow cytometry and Annexin VI and PI stainings indicating
reduced cell viability and cell death, respectively, did not show dif-
ferences between medium and OBW90 stimulated cells (Tang et. al.,
manuscript in preparation) leaving the cause of the reduced mRNA
yield and MTT values in HEK-Blue hTLR4 cells unclear.
Analysing LPS contaminations in HEK-Blue hTLR4 cells at low
polysaccharide concentrations indicated that LCES, Naxus and RG-
1 contained signiﬁcant amounts of LPS and therefore required
treatment. We performed the alkaline-ethanol treatment because
alkali conditions are known to induce de-O-acylation and there-
fore will release phosphate-ester groups and ester-bound fatty
acids in Lipid A (Rosner, Tang, Barzilay, & Khorana, 1979). It has
been shown that the phosphate groups and fatty acids are critical
for Lipid A bioactivity (Bentala et al., 2002; Fukuoka et al., 2001)
and LAL-based detection (Gutsmann et al., 2010). Water-based
alkali treatment to degrade lipid A moieties have been described
as early as the 1980's. In fact, alkaline treatment of both LPS and
contaminated polysaccharide samples has been used as a detox-
iﬁcation strategy (Adam, Vercellone, Paul, Monsan, & Puzo, 1995;
Mikami, Nagase, Matsumoto, Suzuki, & Suzuki, 1982). Alternatively
to de-O-acylation of the Lipid A moiety of LPS, the treatment may
have interfered with physical interactions between LPS and the
polysaccharides. Under alkali conditions, polysaccharides will be
present in a more open, elongated form due to interchain repul-
sion with also a consequent disruption of aggregates (Podzimek,
2011). Such conformational changes may have allowed LPS or the
residual Lipid A to be washed away. Conformation changes like the
disruption of aggregates may also have resulted in reduced activity
since it has been suggested that the biological activity of LPS may
depend on the presence of aggregated LPS units (Mueller et al.,
2004). In a previous study, the stability of the carrageenan back-
bone during acid desulphation was improved in the gel-state
compared to carrageenan in aqueous solution (Zhang, Piculell,
Nilsson, & Knutsen, 1994). The alkaline-ethanol treatment was
therefore carried out in 60% ethanol with the polysaccharides
suspended, but not solubilized. This approach has the additional
advantage of simplifying polysaccharide recovery and salt removal
after neutralization. Alkaline-ethanol treatment of LCES, Naxus
and RG-1 preparations at 56 °C consistently resulted in a dramatic
reduction in residual LPS contamination to o0.02 EU/mg (Fig. 4B)
which is below immune cell response thresholds (Schwarz et al.,
2014). Untreated Wellmune Soluble already demonstrated a LPS
contamination sufﬁciently low to allow in vitro immune analysis
(0.177 EU/mg). OBW90, like LCES and Naxus treated at 56 °C,
contained LPS contaminations below detection threshold, but also
showed strongly reduced cell viability which might prevent efﬁ-
cient SEAP responses to LPS levels and results in a false negative
response. However, in case of OBW90 the spike controls validatethe Endozyme measurements showing a LPS contamination of
0.035 EU/ml (Fig. 1). Interestingly, the alkaline-ethanol treatment
also reduced responses when stimulating HEK-hTLR2 cells with
LCES or Naxus (data not shown). LTA is a classical ligand for TLR2
and contains D-alanine ester residues (Neuhaus, Linzer, & Reusch,
1974). Possibly, in parallel to LPS, de-esteriﬁcation results in the
inactivation of LTA, causing a reduction in TLR2 responses.
Alkaline-ethanol treatment may not only inﬂuence LPS content,
but can also potentially alter the polysaccharide structure and lead to a
degradation. We used SEC-RI as a screening tool to investigate changes
in molar mass (Fig. 5). Especially for OBW90, which is a pure linear
polysaccharide with a unimodal MMD, SEC-RI can be used to monitor
random depolymerisation. Our results clearly demonstrate that alka-
line-ethanol treatment at 56 °C leads to a profound degradation of
OBW90, while treatment at 4 °C does not affect the MMD. For Naxus
we observed a broadening of the unimodal MMD after alkaline-
ethanol treatment at both temperatures. This may be related to
changes in polysaccharide composition as Naxus is not only composed
of arabinoxylan, but also contains a small deﬁned fraction (5% of
sample weight) of galactose containing polymers. We know from
previous results that these galactose constituents can be removed
from Naxus by a similar type of alkali treatment as employed in this
study (data not shown). For RG-1 and Wellmune Soluble we observed
minor differences between MMDs of untreated and alkaline-ethanol
treated polysaccharides. For LCES we show that the B peak has a very
high Mw of 12,000,000 g/mol which might represent aggregations. To
calculate this relative Mw value, the pulullan calibration curve had to
be extrapolated. The given value is therefore most likely an over-
estimation. The obtained MMD can, nevertheless, be used to examine
the effect of alkali treatment on LCES and we demonstrated a dramatic
reduction of the contribution of the B peak to the total area from 74%
in untreated LCES to 20% (4 °C) and 11% (56 °C) in the alkaline-ethanol
treated LCES. The B peak of LCES may represent higher order struc-
tures like triple helixes and re-natured triple helixes. Fungal β-glucans
in aqueous solution have been shown to adopt triple helix structures
which appear important for some biological activity (Bohn & BeMiller,
1995; Falch, Espevik, Ryan, & Stokke, 2000; Zhang, Li, Xu, & Zeng,
2005). Alkali treatment has been shown to disrupt triple helical
structures of fungal β-glucans when applying higher concentrations as
used in this study (e.g., 0.35 M). This denaturation was, however, at
least partly reversible upon neutralisation followed by thermal an-
nealing (Falch et al., 2000; Stokke, Elgsaeter, Brant, & Kitamura, 1991).
Taken together, SEC-RI is a useful tool to visualize the effect of different
alkaline-ethanol treatment conditions on the integrity of poly-
saccharide preparation. However, especially for complex polymodal
and branched polysaccharide preparations, additional structural ana-
lysis like 1HNMR or methylation analysis are required to fully in-
vestigate structural changes.
We have shown that alkaline-ethanol treatment can efﬁciently
inactivate LPS in a variety of polysaccharide preparations and
should be performed at 56 °C for optimal efﬁciency. The treatment
should be combined with assays to validate LPS removal/in-
activation as well as assays on polysaccharide structure since
samples may differ in their susceptibility to alkali treatment and
the efﬁcacy of the treatment for LPS inactivation. SEC-RI proved to
be a useful tool to monitor possible degradation of polysaccharide
samples due to alkaline-ethanol treatment. Most importantly,
however, remains the initial and proper testing of LPS con-
taminations, to prevent false positive immuno-stimulatory results
(Gertsch et al., 2011). For polysaccharides we have demonstrated
that endotoxin test kits are not universally applicable. Proper va-
lidation of results by the inclusion of spike control samples is
crucial. The quantiﬁcation of functional LPS by a HEK-Blue-hTLR4
based assay provides a good alternative method, but should be
accompanied by a cell viability assay. Despite the laborious pro-
cess, proper LPS quantiﬁcation and inactivation/removal of LPS if
C. Govers et al. / Bioactive Carbohydrates and Dietary Fibre 8 (2016) 15–2524present in functional amounts are absolutely essential. In addition
to that, the presence of other contaminants with potential im-
mune-modulating properties has to be taken into account (Di-
narello, Oconnor, Lopreste, & Swift, 1984; Zidek, Kmonickova,
Kostecka, & Jansa, 2013). Speciﬁc enzymatic degradation of the
polysaccharides can be used to conﬁrm that a measured activity is
truly related to a polymeric carbohydrate structure (Rieder et al.,
2013). Only by identifying true polysaccharide-mediated immune-
modulating activities, in vitro analysis can contribute to developing
polysaccharide-based functional foods to aid in, for instance,
treating high cholesterol levels, cancer, IBD and increasing general
health (Gunness & Gidley, 2010; Schwartz & Hadar, 2014).Author disclosure statement
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